PHARMA CONSULT

Brugelette ·KBO/BCE: BE 0782.498.109

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	15-09-2025	46 d late	2025-00493860
31-12-2023	31-07-2024	28-10-2024	89 d late	2024-00516509
31-12-2022	31-07-2023	18-07-2024	353 d late	2024-00270465

Metric	This company	Sector median	Position in the sector
Solvency	70.4%	56.2%	better than 68% of 2542 sector peers
Net result	€79k	€19k	better than 87% of 2544 sector peers
Equity	€262k	€43k	better than 92% of 2542 sector peers
Gross operating margin	€105k	€37k	better than 82% of 2541 sector peers
Staff costs	€671	€14k	higher than 21% of 375 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€371k
Fixed assets	21/28	€3k
Tangible fixed assets	22/27	€3k
Current assets	29/58	€369k
Amounts receivable within one year	40/41	€342k
Cash & bank	54/58	€25k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€371k
Equity	10/15	€262k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€259k
Amounts payable	17/49	€110k
Amounts payable within one year	42/48	€110k
Trade debts payable within one year	44	€766
Income statement
Gross operating margin	9900	€105k
Operating result	9901	€102k
Financial income	75	€4
Financial charges	65	€581
Result before taxes	9903	€102k
Income taxes	67/77	€23k
Net result for the period	9904	€79k
Result to be appropriated	9905	€79k

Summary